Prophylactic treatment of FSGS recurrence in patients who relapsed in a previous kidney graft.
Charlotte Uro-CosteCéline LambertVincent AudardLionel CouziSophie CaillardMatthias BüchlerArnaud Del BelloPaolo MalvezziVincent PerninCharlotte ColosioLaurent MesnardDominique BertrandFrank MartinezDidier DuclouxCoralie PoulainAntoine ThierryClément DanthuClarisse GrezeCamille LanaretValérie MoalAlexandre HertigJacques DantalChristophe LegendreValérie ChateletAntoine SicardClément GossetNicolas MaillardAgnès DuveauClémence PetitNassim KamarAnne-Elisabeth HengDany AnglicheauCyril GarroustePublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
Our study suggests that prophylactic treatment should not be used routinely in patients receiving a second transplantation after recurrence of FSGS on a previous graft. The recurrence rate is high regardless of the use of prophylactic treatment. However, the 5-year graft survival remains satisfactory.